Andrea Spezzi
Founder chez Orchard Therapeutics (Europe) Ltd.
Profil
Andrea Spezzi is the founder of Orchard Therapeutics Plc, Orchard Therapeutics (Europe) Ltd., and Rejuvitas, Inc. Orchard Therapeutics Plc was founded in 2008, Orchard Therapeutics (Europe) Ltd.
was founded in 2015, and Rejuvitas, Inc. was founded in 2021.
Dr. Spezzi is currently an Independent Director at Bloomsbury Genetic Therapies Ltd.
since 2022.
Dr. Spezzi's former positions include Senior Medical Director at GSK Plc and Global Medical Director at Takeda Pharmaceutical Co., Ltd.
Dr. Spezzi received an undergraduate degree from Universidad de Buenos Aires.
Postes actifs de Andrea Spezzi
Sociétés | Poste | Début |
---|---|---|
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Founder | 01/01/2015 |
Rejuvitas, Inc.
Rejuvitas, Inc. BiotechnologyHealth Technology Rejuvitas, Inc. provides biotechnology services. The company is based in Nissequogue, NY. The company was founded by Andrea Spezzi. Andrea Spezzi has been the CEO since incorporation. | Founder | 01/12/2021 |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Director/Board Member | 01/10/2022 |
Anciens postes connus de Andrea Spezzi
Sociétés | Poste | Fin |
---|---|---|
GSK PLC | Chief Tech/Sci/R&D Officer | - |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Chief Tech/Sci/R&D Officer | - |
ORCHARD THERAPEUTICS PLC | Founder | - |
Formation de Andrea Spezzi
Universidad de Buenos Aires | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GSK PLC | Health Technology |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
Entreprise privées | 4 |
---|---|
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
Rejuvitas, Inc.
Rejuvitas, Inc. BiotechnologyHealth Technology Rejuvitas, Inc. provides biotechnology services. The company is based in Nissequogue, NY. The company was founded by Andrea Spezzi. Andrea Spezzi has been the CEO since incorporation. | Health Technology |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Health Technology |